HVR Cardio Oy is a health care startup based in Finland, founded in 2009. The company is focused on developing first-generation transcatheter mitral valve repair solutions. Their patented HELIX ring technology is designed to fit the anatomy of the mitral valve, enabling fast and easy implantation and restoration of the valve geometry, leading to uncompromised clinical efficacy. The minimally invasive technology has the potential to reduce the invasiveness, operation time, and morbidity associated with mitral valve repair operations, thus allowing effective treatment of patients at any stage of mitral valve disease. In their Series B investment round at 11 January 2023, HVR Cardio secured €10.70M from Tesi and Innovestor. Overall, the company's innovative approach to mitral valve repair presents promising opportunities for intervention cardiology and cardiac surgery. Visit hvrcardio.com to learn more.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | €10.70M | 2 |
|
11 Jan 2023 |
No recent news or press coverage available for HVR Cardio Oy.
We care about your data, and we'd love to use cookies make your experience better.
